文献速递神经康复言语与吞咽障碍

咽部电刺激治疗急性卒中吞咽障碍:PhEED临床试验的病例启示

Pharyngeal electrical stimulation to treat dysphagia in acute stroke: learnings from cases in the PhEED clinical trial.
PubMed 文献 · J Rehabil Med · 2025-09-05

PhEED随机假对照盲法多中心试验因招募不足提前终止,15例接受主动刺激、2例接受假刺激。主动刺激在83天时显著降低吞咽障碍严重度(差值-4,p=0.027),未发现干预相关严重不良事件。

要点

  • 咽部电刺激在急性卒中吞咽障碍患者中安全性良好,未观察到干预相关严重不良事件。
  • 主动刺激组第83天吞咽障碍严重度较基线显著改善(差值-4,p=0.027)。
  • 试验因招募缓慢提前终止,主动刺激15例、假刺激仅2例,结论需更大样本验证。

核心结论

  • 咽部电刺激在卒中后吞咽障碍患者中安全,并与吞咽障碍严重度降低相关,需更大规模研究进一步验证。

研究设计与样本

  • 各中心先入组3例开放标签导入期参与者,随后将后续参与者随机分配至刺激组或假刺激组。
  • 研究干预为连续3天、每天10分钟。
  • 数据锁定前主要终点调整为吞咽障碍严重度量表从治疗前至随访结束的变化。
  • 次要结局包括末次治疗后48小时视频透视吞咽造影评估的穿透-误吸量表评分,以及随机化后7、14、83天评估的功能性经口摄食量表。

主要发现

  • 试验因招募缓慢提前终止,15例接受主动刺激、2例接受假刺激。
  • 主动刺激在第83天显著降低吞咽障碍严重度(差值:-4,p=0.027)。
  • 饮食与监护子量表及功能性经口摄食评分观察到改善。
  • 接受治疗者中67%出院回家。
  • 两组均未记录到归因于干预的严重不良事件。

关键数值与推荐

  • 纳入标准:急性缺血性或出血性卒中伴吞咽障碍,视频透视吞咽造影穿透-误吸量表评分4-8分。
  • 干预方案:每日10分钟,连续3天。
  • 主要终点:吞咽障碍严重度量表从治疗前至随访结束的变化(数据锁定前调整)。
  • 次要终点:末次治疗后48小时穿透-误吸量表评分;随机化后7、14、83天功能性经口摄食量表评分。
  • 主动刺激组第83天吞咽障碍严重度较基线差值-4(p=0.027)。

临床怎么用

  • 咽部电刺激可作为急性卒中吞咽障碍的辅助治疗选择,治疗期间未观察到干预相关严重不良事件。
  • 疗效评估可结合吞咽障碍严重度量表、穿透-误吸量表及功能性经口摄食量表进行多维随访。
  • 因证据样本量小且假刺激组仅2例,临床应用需谨慎,不宜替代标准吞咽康复方案。

局限性

  • 试验因招募缓慢提前终止,主动刺激15例、假刺激仅2例,组间样本量严重不平衡。
  • 主要终点在数据锁定前由原计划调整而来。
  • 样本量小且假对照例数极少,疗效估计的可靠性有限,需更大规模研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the efficacy of pharyngeal electrical stimulation in improving dysphagia post-stroke. DESIGN: A randomized, sham-controlled, blinded multicentre clinical trial. SUBJECTS/PATIENTS: Seventeen patients with acute ischaemic or haemorrhagic stroke experiencing dysphagia, indicated by a penetration aspiration scale score of 4-8 on videofluoroscopy. METHODS: Sites enrolled 3 open-label roll-in participants and then randomized subsequent participants to either stimulation or sham treatment. Study interventions were delivered for 10 min daily over 3 consecutive days. Prior to data lock the primary outcome was modified to the change in dysphagia severity rating scale from pre-treatment to end of follow-up period. Secondary outcomes included penetration-aspiration scale score assessed via videofluoroscopy 48 h after final treatment and functional oral intake scale, measured at 7, 14, and 83 days post-randomization. RESULTS: The trial was halted early due to low recruitment, with 15 participants receiving active stimulation and 2 receiving sham treatment. Active stimulation significantly reduced dysphagia severity at day 83 (difference: -4, p = 0.027). Improvements were observed in diet and supervision subscales, and functional oral intake scores. Of those treated, 67% were discharged home, with no serious adverse events attributable to the intervention noted in either group. CONCLUSION: Pharyngeal electrical stimulation was safe and associated with reduced dysphagia severity in stroke patients, warranting further validation in larger studies.

来源:J Rehabil Med,查看原文。版权归原作者所有。

引用

  1. Harvey RL, Smith R, Bathula R, et al. Pharyngeal electrical stimulation to treat dysphagia in acute stroke: learnings from cases in the PhEED clinical trial. J Rehabil Med. 2025. PMID: 40908833. doi:10.2340/jrm.v57.43538

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。